Showing results (991-1000 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|April 29, 2016
Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in SwedenDonghao Lu, Therese M L Andersson, Katja Fall, et al.JAMA Oncology|June 3, 2016
Management of Ductal Carcinoma In Situ of the Breast: A ReviewChirag Shah, Jessica Wobb, Bindu Manyam, et al.JAMA Oncology|June 9, 2016
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic ReviewLola Rahib, Julie M Fleshman, Lynn M Matrisian, et al.JAMA Oncology|November 10, 2017
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate CancerJosef J Fox, Somali C Gavane, Estelle Blanc-Autran, et al.JAMA Oncology|December 10, 2017
Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD StudySusan Slovin, William Clark, Joan Carles, et al.JAMA Oncology|November 24, 2017
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results ProgramCaitlin C Murphy, David E Gerber, Sandi L PruittJAMA Oncology|October 20, 2017
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate CancerJason W D Hearn, Wanling Xie, Mari Nakabayashi, et al.JAMA Oncology|September 8, 2017
Effect of Modified Vaccinia Ankara-5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer: A Randomized Clinical TrialMartin Scurr, Tom Pembroke, Anja Bloom, et al.JAMA Oncology|September 15, 2017
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest GroupMei Guo, Nelson J Chao, Jian-Yong Li, et al.JAMA Oncology|September 15, 2017
Identification of ALK Rearrangements in Malignant Peritoneal MesotheliomaYin P Hung, Fei Dong, Jaclyn C Watkins, et al.Pageof 161